Giotrif

Giotrif (Afatinib) is an oral medication used to treat specific types of cancer. This targeted therapy is designed to inhibit certain proteins that contribute to cancer cell growth.

Giotrif is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. It works by targeting and blocking proteins that help cancer cells grow and divide. Patients often wonder, 'What is Giotrif used for?' This medication is part of a class of drugs known as tyrosine kinase inhibitors, which are used in cancer treatment to slow the progression of the disease.

Common effects of Giotrif may include skin rash, diarrhea, and fatigue. Some patients may also experience nausea or loss of appetite. These effects can vary in severity and duration, and it's important to discuss any concerns with a healthcare provider.

Giotrif should be handled with care, as it is intended for oral use only. It is important to follow the guidance of a healthcare professional regarding its use. Patients should be aware of potential side effects and report any severe or persistent symptoms to their doctor.

Giotrif may interact with certain medications, including those that are metabolized by the liver. It is advisable to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Giotrif.